儿童增强CT使用高压注射器对比剂外渗的频率与损伤严重程度
该回顾性研究纳入1496例儿童增强CT,评估高压注射器对比剂外渗的发生率与损伤严重程度。外渗18例(轻度7例、中度6例、重度5例),外渗组峰值压力及流率显著更高,使用碘海醇-350者外渗显著多于碘海醇-300,但事后校正后仅峰值压力和流率仍显著。结论认为高压注射器用于儿童增强CT外渗率低且长期损伤少。
要点
- 儿童增强CT高压注射对比剂外渗率低,且长期损伤少。
- 外渗组峰值压力和流率显著高于无外渗组(p<0.001)。
- 使用碘海醇-350者外渗显著多于碘海醇-300(p=0.03),事后校正后不显著。
核心结论
- 儿童增强CT使用高压注射器对比剂外渗率低且长期损伤少。
研究设计与样本
- 经IRB批准、符合HIPAA的回顾性研究,3年内共2429例儿童增强CT,最终分析1496例(男823例、女673例),使用高压注射器,统计患者人口学、注射器及对比剂信息、症状、损伤严重程度和治疗。
诊断标准与关键数值
- 外渗18例,平均年龄11.2±6.2岁,其中轻度7例、中度6例、重度5例。
- 外渗组峰值压力显著高于无外渗组(p<0.001)。
- 外渗组流率显著高于无外渗组(p<0.001)。
- 使用碘海醇-350者对比剂外渗显著多于使用碘海醇-300者(p=0.03),事后校正后不显著。
- 事后校正后仅峰值压力(p<0.01)和流率(p=0.01)仍显著。
临床应用与阅片要点
- 儿童增强CT使用高压注射器时,峰值压力和流率与外渗相关,可关注这两个参数。
- 使用碘海醇-350者外渗多于碘海醇-300,但事后校正后不显著,原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the safety of power injectors for contrast-enhanced computed tomography (CT) in children, namely: the prevalence and injury severity of contrast extravasations related to power injectors and the factors associated with these events.
METHODS: The need to obtain informed consent was waived for this HIPAA-compliant and IRB approved retrospective study. Around 2429 contrast-enhanced CT performed with a power injector were identified during a 3-year period. Data collected included patient demographic, power injector, and contrast agent information. The patients' symptoms, severity of injury and treatment with contrast extravasation were recorded. Around 1496 cases (823 boys, 673 girls) were included in the analysis. Independent-sample t test and Chi-square were used. For a sub-analysis using the extravasation cases, nonparametric tests were used.
RESULTS: The mean age was 9.5 ± 6.1 years. The most common access site, catheter site, and contrast agent used were the antecubital fossa, 22 gauge and Iohexol. The mean peak pressure was 68.9 ± 62.3 psi and the flow rate was 1.7 ± 0.9 mL/s. Eighteen cases of contrast extravasation were identified with a mean age of 11.2 ± 6.2 years. There were seven mild, six moderate, and five severe. Cases with extravasation had significantly higher peak pressure (p < 0.001) and flow rate (p < 0.001) compared to those without extravasation. Patients who received Iohexol-350 had significantly more contrast extravasation compared to those who used Iohexol-300 (p = 0.03). However, after post-hoc correction, only peak pressure (p < 0.01) and flow rate (p = 0.01) remained significant.
CONCLUSION: The use of power injectors in children undergoing contrast-enhanced CT is associated with a low rate of extravasation and of long-term injury.
引用
- Barrera CA, White AM, Shepherd AM, et al. Contrast Extravasation using Power Injectors for Contrast-Enhanced Computed Tomography in Children: Frequency and Injury Severity. Acad Radiol. 2019. PMID: 31138458. doi:10.1016/j.acra.2019.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。